MYP_007211
Basic Information
Pancrelipase protease
Therapeutic / Biomedical activity Enzyme replacement therapy
Standard
231 amino acids
C1060H1662N296O338S14
Standard
Sequence
FPTDDDDKIVGGYTCAANSIPYQVSLNSGSHFCGGSLINSQWVVSAAHCYKSRIQVRLGEHNIDVLEGNEQFINAAKIITHPNFNGNTLDNDIMLIKLSSPATLNSRVATVSLPRSCAAAGTECLISGWGNTKSSGSSYPSLLQCLKAPVLSDSSCKSSYPGQITGNMICVGFLEGGKDSCQGDSGGPVVCNGQLQGIVSWGYGCAQKNKPGVYTKVCNYVNWIQQTIAAN
Physicochemical Analysis
24409.22 Da
7.00
-0.00
-0.63
-0.0000
-0.11
0.55
0.11
31.71
80.61
0.0736
33920.00
34670.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0260478 VERIFIED: NO
Provenance & Taxonomy
Sus scrofa [Animal]
Enzyme
9823
Structure & Mods
linear peptide/protein therapeutic [Linear]
canonical L-amino-acid peptide [L]
Disulfide-bonded therapeutic scaffold described in source text
Bio-Activity Profile
Enzyme replacement
Pancrelipase acts locally in the GI tract and it is not absorbed in any significant amount thus, the elimination half-life is not relevant.74